Medscape InDiscussion: Multiple Myeloma
Episodes
S2 Episode 6: What Is the Future of Multiple Myeloma?
18 Dec 2025
Contributed by Lukas
Drs Joseph Mikhael and Shaji Kumar discuss the future of multiple myeloma, including enhanced diagnostics for detecting myeloma, frontline therapy, an...
S2 Episode 5: Is It Time to Screen for Multiple Myeloma?
20 Nov 2025
Contributed by Lukas
Drs Joseph Mikhael and Sigurdur Y. Kristinsson discuss whether it is time to screen for multiple myeloma and what we can learn from the iStopMM study....
S2 Episode 4: Should You Treat Smoldering Multiple Myeloma?
22 Oct 2025
Contributed by Lukas
Drs Joseph Mikhael and Peter Voorhees discuss considerations for treating smoldering multiple myeloma, including recent studies and shared decision-ma...
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
23 Sep 2025
Contributed by Lukas
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridgin...
S2 Episode 2: Should All Newly Diagnosed Multiple Myeloma Patients Be Treated With a Quadruplet in Frontline Therapy?
21 Aug 2025
Contributed by Lukas
Drs Joseph Mikhael and Saad Usmani discuss why quadruplet therapy is now the new standard of care for treating newly diagnosed multiple myeloma patien...
S2 Episode 1: Managing Side Effects and Maximizing Quality of Life in Multiple Myeloma Patients
21 Aug 2025
Contributed by Lukas
Joseph Mikhael, MD, and Surbhi Sidana, MD, discuss the importance of balancing treatment intervals, managing side effects, and maximizing quality of l...
S1 Episode 6: Disparities in Multiple Myeloma: Exposing the Problem and Paving a Path Forward
06 Sep 2022
Contributed by Lukas
Drs Joseph Mikhael and Brandon Blue reveal the impact of disparities in multiple myeloma and pave a path forward to culturally competent care. Relevan...
S1 Episode 5: Multiple Myeloma Therapies: A Glimpse Into the Future
10 Aug 2022
Contributed by Lukas
Drs Joseph Mikhael and Nina Shah discuss the exciting future in multiple myeloma in which bispecifics, CELMoDs, modakafusp, and easily delivered CAR T...
S1 Episode 4: Triple-Class Refractory Multiple Myeloma: What Is the Approach? What Are the Challenges?
05 Jul 2022
Contributed by Lukas
Joseph Mikhael, MD, and Saad Usmani, MD, discuss options in managing triple-class refractory multiple myeloma including selinexor, belantamab mafodoti...
S1 Episode 3: Addressing Comorbidities in Multiple Myeloma: Treating People, Not the Disease
02 Jun 2022
Contributed by Lukas
Joseph Mikhael, MD, and Ashley Rosko, MD, discuss the role of comorbidities in multiple myeloma and stress the importance of shifting away from the so...
S1 Episode 2: Frontline Therapy for Multiple Myeloma
03 May 2022
Contributed by Lukas
Joseph Mikhael, MD, and Peter Voorhees, MD, discuss frontline therapy for multiple myeloma and new options for both transplant-eligible and transplant...
S1 Episode 1: Avoiding the Cliff: Screening for Early-Stage Multiple Myeloma
03 May 2022
Contributed by Lukas
Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it. ...